Dow Up 0.18% Nasdaq Down 0.01%

Nektar Therapeutics (NKTR)

-NasdaqGS
13.49 Down 0.11(0.84%) 11:33AM EDT - Nasdaq Real Time Price
Prev Close:13.60
Open:13.52
Bid:13.49 x 900
Ask:13.50 x 100
1y Target Est:16.56
Beta:1.48
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:13.44 - 13.60
52wk Range:8.87 - 15.34
Volume:120,187
Avg Vol (3m):1,148,560
Market Cap:1.72B
P/E (ttm):N/A
EPS (ttm):-1.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NKTR

Comparison

Symbol% ChgMkt Cap
NKTRDown 0.84%1.72B
BMYDown 0.52%82.96B
ENZN 0.00%55.60M
GSKUp 0.15%113.90B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.34
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.65
Quarterly EPS Est (Sep-14) :0.39
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-0.67

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nektar Therapeutics, a clinical-stage biopharmaceutical company, develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback